Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...

Here are three reasons why Pfizer could prove to be a steal of a deal this year. Buying quality stocks at decent valuations ...

Healthcare is a defensive sector that is more resilient to economic downturns than most others. That's one of several reasons ...

The disposal represents Pfizer's exit from its investment in Haleon, which originated from a JV formed with GSK in 2019.

Amid rising risks, I favor high-yield stocks with strong business models. Check out the stock picks that offer stability, ...

Pfizer (NYSE:PFE – Get Free Report)‘s stock had its “buy” rating restated by research analysts at Guggenheim in a research ...

The stock market's performance in the coming year feels less certain than usual. Luckily, there's a well-established, ...